Hoth Therapeutics receives Nasdaq deficiency notice for minimum bid price non-compliance

Hoth Therapeutics, Inc.

Nasdaq notified HOTH on Oct 30, 2024 that common stock failed minimum $1.00 bid price for 30 consecutive business days.
Common stock continues trading on Nasdaq Capital Market under HOTH; no immediate effect on listing.
Company has 180 days, until April 28, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant by April 28, 2025, an additional 180-day period may be granted if other listing requirements are met.
Company may consider implementing a reverse stock split to cure the deficiency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.